Oct 30 (Reuters) – Boehringer Ingelheim: * BOEHRINGER INGELHEIM REGISTERS PHASE III TRIAL INVESTIGATING VERDUCATIB IN COPD Source text:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Kanjyik Ghosh Oct 30 (Reuters) - The global Financial Action Task Force watchdog on…
Oct 30 (Reuters) - Tottenham Hotspur midfielder James Maddison is available to face Crystal Palace…
By Michael S. Derby Oct 30 (Reuters) - St. Louis Federal Reserve President Alberto Musalem…
By Diana Novak Jones Oct 30 (Reuters) - Meta Platforms has settled with a teen plaintiff who…
FINANCIAL ACTION TASK FORCE LEAVES MYANMAR ON ‘BLACK LIST’, STRENGTHENS WARNING (The article has been…
By Ammu Kannampilly NAIROBI, Oct 30 (Reuters) - Engineering giant Fluor Corp is among a…